Related by context. Frequent words. (Click for all words.) 63 placebo controlled clinical 60 Pivotal Phase III 60 Pivotal Trial 60 tesmilifene 60 phase IIa 59 phase IIb 58 multicenter clinical 58 tipranavir 58 axitinib 58 randomized controlled clinical 57 TRITON TIMI 57 placebo controlled randomized 57 Phase 1b clinical 57 prospective randomized controlled 57 darapladib 57 methylnaltrexone 57 tocilizumab 56 ELND# 56 Telcyta 56 tanespimycin 56 multicenter randomized 56 Phase III randomized 56 randomized Phase III 56 RTOG 56 Sorafenib 56 active comparator 56 COPAXONE R 55 Phase III 55 Azedra 55 decitabine 55 blind randomized controlled 55 BAY #-# 55 ocrelizumab 55 Alemtuzumab 55 Mylotarg 55 COPAXONE ® 55 ATTRACT 55 ASA# 55 TELCYTA 55 sunitinib 55 Phase Ia 55 NOXAFIL 55 PROMACTA 55 CoFactor 55 EORTC 55 SPIRIT III 55 Phase IIa clinical 54 SUTENT 54 randomized clinical 54 HuMax CD# 54 TroVax 54 Phase 1a 54 glufosfamide 54 dabigatran etexilate 54 double blinded placebo 54 Allovectin 7 R 54 multicentre 54 ISIS # 54 Desmoteplase 54 blinded placebo controlled 54 Myocardial Infarction 54 eltrombopag 53 lupus nephritis 53 Phase 2a trial 53 virologic response 53 Cethrin 53 multicenter randomized double 53 Phase IIb clinical 53 Phase Ib 53 PF # [001] 53 AP# [003] 53 Phase 2b clinical 53 Phase 2b 53 valopicitabine 52 relapsed refractory multiple myeloma 52 vandetanib 52 Phase 2a clinical 52 Laquinimod 52 Phase 2b trial 52 rNAPc2 52 LymphoStat B 52 Phase III clinical 52 hepatitis C HCV 52 diabetic neuropathic pain 52 PEG Interferon lambda 52 Androxal 52 Congestive Heart Failure 52 nab paclitaxel 52 pivotal Phase III 52 TASQ 52 SCH # 52 Phase 1b 52 elesclomol 52 Bapineuzumab 52 VEGF Trap 52 Phenoptin 52 Bronchitol 52 6R BH4 52 Acute Coronary Syndrome 52 temsirolimus 52 secondary efficacy endpoints